MANCINA, ROSELLINA MARGHERITA
 Distribuzione geografica
Continente #
AS - Asia 1.302
NA - Nord America 664
SA - Sud America 391
EU - Europa 287
Continente sconosciuto - Info sul continente non disponibili 123
AF - Africa 22
AN - Antartide 1
Totale 2.790
Nazione #
US - Stati Uniti d'America 606
SG - Singapore 392
BR - Brasile 302
HK - Hong Kong 219
CN - Cina 200
VN - Vietnam 150
KR - Corea 139
BD - Bangladesh 122
IT - Italia 113
AR - Argentina 39
FR - Francia 39
GB - Regno Unito 29
CA - Canada 23
ID - Indonesia 22
DE - Germania 20
EC - Ecuador 16
MX - Messico 15
PL - Polonia 14
CO - Colombia 12
IN - India 12
ZA - Sudafrica 10
PY - Paraguay 9
LT - Lituania 8
NL - Olanda 8
UA - Ucraina 8
IQ - Iraq 7
RU - Federazione Russa 7
SE - Svezia 7
ES - Italia 6
JM - Giamaica 6
CH - Svizzera 5
EG - Egitto 5
JP - Giappone 5
PE - Perù 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
BE - Belgio 4
HN - Honduras 4
KG - Kirghizistan 4
TR - Turchia 4
AE - Emirati Arabi Uniti 3
EE - Estonia 3
PK - Pakistan 3
PT - Portogallo 3
UY - Uruguay 3
VE - Venezuela 3
AL - Albania 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
GH - Ghana 2
GR - Grecia 2
IE - Irlanda 2
KZ - Kazakistan 2
MA - Marocco 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HT - Haiti 1
IL - Israele 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
PH - Filippine 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.669
Città #
Hong Kong 219
Singapore 153
Seoul 139
Ashburn 96
Council Bluffs 79
Chicago 70
Ho Chi Minh City 57
San Jose 52
Beijing 46
Hanoi 29
São Paulo 28
Los Angeles 19
Frankfurt am Main 15
New York 15
Hillsboro 14
Rio de Janeiro 13
Warsaw 13
Dallas 12
Santa Clara 12
Rome 10
Haiphong 9
Milan 9
Guayaquil 8
London 8
Buffalo 7
Dhaka 7
Montreal 7
Naples 7
Da Nang 6
Phoenix 6
Reston 6
Belo Horizonte 5
Belém 5
Gothenburg 5
Lima 5
Mexico City 5
Santo André 5
Tashkent 5
Thái Bình 5
Tokyo 5
Toronto 5
Zurich 5
Baghdad 4
Bishkek 4
Boston 4
Brasília 4
Brussels 4
Curitiba 4
Florence 4
Hải Dương 4
Johannesburg 4
Juiz de Fora 4
Medellín 4
Palermo 4
Potenza 4
Quito 4
São José dos Campos 4
Araçatuba 3
Bari 3
Betim 3
Bexley 3
Biên Hòa 3
Bogotá 3
Cairo 3
Can Tho 3
Caxias do Sul 3
Cologna Veneta 3
Dubai 3
Florianópolis 3
Kingston 3
Limburg an der Lahn 3
Manchester 3
Montevideo 3
Ninh Bình 3
Orem 3
Ottawa 3
Philadelphia 3
Quilmes 3
Ribeirão Preto 3
Riyadh 3
Rondonópolis 3
San Francisco 3
St Petersburg 3
São José 3
São José do Rio Preto 3
Tallinn 3
Uberlândia 3
Accra 2
Amsterdam 2
Ankara 2
Araguaína 2
Athens 2
Augusta 2
Açailândia 2
Bento Gonçalves 2
Boardman 2
Bologna 2
Bratislava 2
Brooklyn 2
Buenos Aires 2
Totale 1.402
Nome #
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 84
Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation. 77
Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan 57
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 56
PSD3 downregulation confers protection against fatty liver disease 56
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 51
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 50
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 50
TM6SF2 and PNPLA3: a potential dynamic duo? 49
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 48
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 48
Cellular Genome-Scale Metabolic Modeling Identifies New Potential Drug Targets Against Hepatocellular Carcinoma 47
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 47
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage 46
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 46
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 46
Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels 45
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells 45
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia 45
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity 45
PNPLA3 I148M polymorphism and progressive liver disease 44
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover 44
Cross talk between liver and adipose tissue: A new role for PNPLA3? 43
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning 43
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 43
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 42
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans 42
Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function 42
Genetic variants in the MTHFR are not associated with fatty liver disease 42
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 41
ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesity 41
Genome-wide interaction study with BMI identifies CYP7A1 and GIPR as genetic modulators of MASLD 40
PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity 39
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 39
Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults 39
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 38
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 38
New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History 38
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 36
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice 35
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 35
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome 35
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease 35
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes 35
High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease 35
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids 35
The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese children 34
Gastrointestinal Symptoms of and Psychosocial Changes in Inflammatory Bowel Disease: A Nursing-Led Cross-Sectional Study of Patients in Clinical Remission 34
Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant 34
MBOAT7 is anchored to endomembranes by six transmembrane domains 33
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans 33
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 33
Genetic diagnosis of familial hypercholesterolaemia by targeted next‐generation sequencing 33
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 32
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis 32
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals 32
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro 32
The IRS1 rs2943641 Variant and Risk of Future Cancer Among Morbidly Obese Individuals 31
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans 31
Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children 30
Statin use and non-alcoholic steatohepatitis in at risk individuals 29
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells 29
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 28
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids 28
Natural Extracts as Modifiers of Intracellular Lipid Handling 28
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 26
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with non-alcoholic fatty liver 25
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 24
Validation of Interleukin-32 as a new circulating fatty liver biomarker 24
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia 24
Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism 8
MTARC1 p.A165 ablation reduces hepatocellular carcinoma aggressiveness in vitro and in vivo 6
Totale 2.790
Categoria #
all - tutte 28.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202467 0 0 0 0 0 0 0 0 30 36 0 1
2024/2025720 19 55 2 9 98 147 76 25 66 38 154 31
2025/20261.790 118 115 299 367 160 26 62 132 152 101 163 95
2026/2027213 61 39 27 86 0 0 0 0 0 0 0 0
Totale 2.790